GTCM
SEM

Gyon Technologies Capital Management’s Select Medical SEM Stock Holding History

Gyon Technologies Capital Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,500
Closed -$304K – 593
2022
Q3 		$304K Buy
+25,500
New +$362K 0.1% 275
2021
Q3 		– Sell
-12,244
Closed -$279K – 477
2021
Q2 		$279K Buy
+12,244
New +$254K 0.09% 288

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Gyon Technologies Capital Management's SEM Position: Q4 2022 in Review

Gyon Technologies Capital Management sold out of Select Medical (SEM) in Q4 2022, closing a stake of 25,500 shares — an estimated $304K sold.

Gyon Technologies Capital Management first reported a position in SEM in Q2 2021 and held it in 2 quarters. The position peaked at $304K in Q3 2022. 211 funds tracked by Wall St. Rank hold SEM as of Q4 2022.

  • Gyon Technologies Capital Management reported no remaining Select Medical position as of Q4 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 25,500 Select Medical shares in Q4 2022, an estimated $304K.
  • Gyon Technologies Capital Management first reported a position in Select Medical in Q2 2021 and held it in 2 quarters.
  • Gyon Technologies Capital Management's Select Medical position peaked at $304K in Q3 2022.
  • 211 funds tracked by Wall St. Rank held Select Medical as of Q4 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.